Relationships between plasma levels of catecholamines and neuropeptides and the survival time in patients with congestive heart failure

This publication has 22 references indexed in Scilit:

• Increased plasma level of substance P in patients with severe congestive heart failure treated with ACE inhibitors
  Journal of Internal Medicine, 1991
• Increased plasma levels of neuropeptide Y-like immunoreactivity and catecholamines in severe hypertension remain after treatment to normotension in man
  Regulatory Peptides, 1991
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.
  Circulation, 1990
• Congestive heart failure: involvement of perivascular peptides reflecting activity in sympathetic, parasympathetic and afferent fibres
  European Journal of Clinical Investigation, 1990
• Contributions of neuroendocrine and local autocrine-paracrine mechanisms to the pathophysiology and pharmacology of congestive heart failure
  The American Journal of Cardiology, 1988
• Possible relationship between neuropeptide Y (NPY) and major depression – evidence from human and animal studies
  Nordisk Psykiatrisk Tidsskrift, 1988
• Effects of Enalapril on Mortality in Severe Congestive Heart Failure
  New England Journal of Medicine, 1987
• Calcitonin Gene-Related Peptide in Thyroid Nerve Fibers and C Cells: Effects on Thyroid Hormone Secretion and Response to Hypercalcemia*
  Endocrinology, 1986
• Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
  New England Journal of Medicine, 1984
• Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: Comparison with a radioenzymatic method
  Life Sciences, 1979